pharming.com - PHAR Net Assets per Single Share

Graphic logo of Pharming Group N.V. (PHAR)

The market value dynamics for Pharming Group N.V. (PHAR) on GURU.Markets, with a metric of 3.65, highlight the business's vulnerability due to its bet on Ruconest and the complexities of clinical trials. However, demand in the US and Europe is rising, as the rare pathology niche remains underserved. Success is driven by competent executives who are effectively scaling sales and integrating new developments into the portfolio.

Pharming Group NV (PHAR): Share Book Value from 07/04/2022 to 10/27/2026

pharming.com - analytical breakdowns and key metrics (PHAR)

- price and consensus price forecast:
Stock Price Pharming|PHAR - Analyst Consensus Forecast
- market capitalization data:
Market Value Pharming Group N.V.|PHAR - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Pharming Group|PHAR - Net Asset Value|Market Capitalization to Book Value Ratio pharming.com|PHAR - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Pharming Group N.V.|PHAR - Long-Term Debt to Capital|Short-Term Debt to Equity Pharming Group|PHAR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Pharming Group N.V.
Fundamental company valuation:Pharming - PHAR
Manufactured products of Pharming Group

Conservative capital demands maximum transparency of the net asset structure to confirm business resilience. This indicator determines the residual value of a single share by dividing the difference between all assets and liabilities by the number of securities. Stable demand for angioedema therapy provides Pharming Group N.V. (PHAR) with a predictable capital inflow, which directly impacts balance sheet capitalization. The historical valuation of the book value per share clearly demonstrates the dynamics of this fundamental reserve.

Competitors of Pharming Group N.V. (PHAR)

Argenx - Book Value per Share|BNTX: Book Value per Share|Net Assets per Single Share Abivax Corp ABVX|ADMA (admabiologics.com) - Accounting Value of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Astria Therapeutics Inc - Net Asset Value per Share|Net Assets per Single Share enGene Bio|RAPT - Share Book Value|Book Value per Share aerovatetx.com JBIO|aclaristx.com (ACRS) - Accounting Value of a Share|KYTX (Kyverna Therapeutics, Inc.) - Book Value per Share|Book Value per Share TLSA|Cabaletta Bio, Inc (CABA) - Net Assets per Single Share|Accounting Value of a Share VTYX (Ventyx Biosciences, Inc)|Theratechnologies Inc. - Net Assets per Single Share|Accounting Value per Share avalotx.com AVTX|Book Value per Share ELDN (Eledon Pharmaceuticals, Inc.)|AGEN: Net Assets per Share|Net Assets per Single Share Climb Bio, Inc.|Zura Bio Ltd (ZURA) - Equity per Share|aTyr Pharma, Inc. - Book Value per Share|Book Value of One Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|EQ (Equillium) - Book Value per Share|Connect Biopharma Holdings - Book Value of One Share|Net Assets per Single Share Immunic Inc (IMUX)|ATRA: Accounting Value of a Share|Net Assets per Single Share IFRX|Net Asset Value per Share X4 Pharmaceuticals Inc.|ACET (Adicet Bio Inc.) - Accounting Value per Share|Book Value per Share CELU|INMB - Net Assets per Single Share|Share Book Value barinthusbio.com BRNS|Accounting Value per Share Kezar Life Sciences, Inc.|SAB Biotherapeutics Inc. - Accounting Value of a Share|Akari Therapeutics plc (AKTX) - Net Assets per Single Share|Enlivex Therapeutics (ENLV) - Equity per Share|q32bio.com - Accounting Value per Share|Net Assets per Share geovax.com|Accounting Value per Share Edesa Biotech|Net Assets per Single Share iBio Inc (IBIO)|CARM (Carisma Therapeutics) - Accounting Value per Share|Net Assets per Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. (BOLT) - Net Assets per Single Share|Share Book Value HCW Biologics, Inc. HCWB|Book Value per Share Aptevo (APVO)|AIM - Accounting Value of a Share|ADTX: Book Value per Share|GRI (GRI Bio Corporation) - Book Value per Share|XRTX - Net Assets per Single Share|Accounting Value of a Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD